Molecular 'Zipper' System Delivers Autophagy-Triggering Peptides Into Cells Without Toxicity

What the researchers found

Coiled-coil molecular zippers with 3 and 4 repeating units (K/E zipper n=3 and n=4) formed stable 1:1 hybrid complexes between the autophagy-inducing peptide and the cell-penetrating peptide. Both successfully delivered the functional peptide into cells.

Interestingly, the 3-repeat zipper induced autophagy more intensively than the 4-repeat version, suggesting that the optimal biological activity depends on a balance between how strongly the zipper holds together and how readily it releases the functional peptide inside the cell. Shorter zippers (n=1 and n=2) did not form stable hybrids. None of the peptides or zippers showed significant cytotoxicity.

Why it matters

Many promising therapeutic peptides fail because they cannot get inside cells where they need to work. This modular zipper delivery system is significant because it allows researchers to fine-tune how peptides are transported into cells and released, without chemically modifying the therapeutic peptide itself. The approach could be adapted for delivering many different types of functional peptides beyond autophagy inducers.

How the study worked

The researchers synthesized autophagy-inducing peptides conjugated to one half of a coiled-coil zipper (K strand) of varying lengths (1-4 repeats), paired with cell-penetrating peptides attached to the complementary half (E strand). They used fluorescence spectroscopy to assess hybrid formation stability, cell delivery assays to confirm intracellular uptake, autophagy assays to measure biological activity, and cytotoxicity assays to confirm safety.

What this study cannot tell us

This was an in vitro cell culture study, so it is unknown whether the zipper system would work in living organisms where factors like blood stability, immune recognition, and tissue penetration come into play. The study tested only one functional peptide (the autophagy inducer), so generalizability to other therapeutic peptides is assumed but not proven. Quantitative data on autophagy levels and delivery efficiency were limited to relative comparisons.

How to read the evidence

This is an early-stage in vitro proof-of-concept study demonstrating a peptide delivery engineering approach. The results are clear and consistent but limited to cell culture experiments without quantitative dose-response data.

When this study was published

Published in 2023, this is recent research in the active field of peptide delivery engineering and autophagy therapeutics.

The bigger picture

This work contributes to the growing field of peptide drug delivery engineering. Autophagy — the cell's process of cleaning up damaged components — is a therapeutic target in cancer, neurodegeneration, and aging. Developing non-toxic systems to deliver autophagy-inducing peptides into cells could unlock new treatments for these conditions. The modular design means the zipper system could potentially be paired with many different functional peptides.

Questions still open

• Would the 3-repeat zipper system maintain its delivery efficiency and autophagy-inducing activity in animal models?
• Can this coiled-coil zipper approach be adapted to deliver other types of therapeutic peptides, such as anticancer or anti-inflammatory peptides?
• What is the precise mechanism by which the zipper dissociates inside the cell to release the functional peptide?

Common questions

Read the original research

Adjusting Heterodimeric Coiled-Coils (K/E Zipper) to Connect Autophagy-Inducing Peptide with Cell-Penetrating Peptide.

Pharmaceutics, 15(4)

Citation

Hakata, Yoshiyuki; Yamashita, Kazuma; Hashimoto, Sonoko; Ohtsuki, Takashi; Miyazawa, Masaaki; Kitamatsu, Mizuki. (2023). Adjusting Heterodimeric Coiled-Coils (K/E Zipper) to Connect Autophagy-Inducing Peptide with Cell-Penetrating Peptide.. Pharmaceutics, 15(4). https://doi.org/10.3390/pharmaceutics15041048